About
Plasmid-based Neoantigen-targeted Cancer Therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalGene Therapy, RNA & Peptide TherapyNJ, NY, PA
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
45
By Phase
PHASE1: 1PHASE1/PHASE2: 1
By Status
ACTIVE_NOT_RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT04015700Collaborator
Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma
PHASE1Active, not recruiting
9 participants
Started: Jul 14, 2020 · Completed: Dec 31, 2025
NCT04251117Lead Sponsor
GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects with Advanced HCC
PHASE1/PHASE2Active, not recruiting
36 participants
Started: Mar 1, 2020 · Completed: Nov 29, 2028
Locations (1)
Headquarters
Philadelphia, PA, United States
Map
Loading map...